Log in

NASDAQ:APENApollo Endosurgery Stock Price, Forecast & News

$2.17
-0.13 (-5.65 %)
(As of 04/10/2020 08:55 AM ET)
Add
Compare
Today's Range
$2.14
Now: $2.17
$2.33
50-Day Range
$1.29
MA: $2.25
$2.92
52-Week Range
$1.24
Now: $2.17
$4.08
Volume3,158 shs
Average Volume12,259 shs
Market Capitalization$45.44 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing System that enables advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope; Orbera365 Managed Weight Loss System; and the BIB for the treatment of overweight and obese adults. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Read More
Apollo Endosurgery logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APEN
CUSIPN/A
Phone512-279-5100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$50.71 million
Book Value$0.10 per share

Profitability

Net Income$-27,430,000.00

Miscellaneous

Employees215
Market Cap$45.44 million
Next Earnings Date5/7/2020 (Estimated)
OptionableNot Optionable

Receive APEN News and Ratings via Email

Sign-up to receive the latest news and ratings for APEN and its competitors with MarketBeat's FREE daily newsletter.


Apollo Endosurgery (NASDAQ:APEN) Frequently Asked Questions

How has Apollo Endosurgery's stock been impacted by COVID-19 (Coronavirus)?

Apollo Endosurgery's stock was trading at $2.0650 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, APEN stock has increased by 5.1% and is now trading at $2.17. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Apollo Endosurgery?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Endosurgery in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Apollo Endosurgery.

When is Apollo Endosurgery's next earnings date?

Apollo Endosurgery is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Apollo Endosurgery.

How were Apollo Endosurgery's earnings last quarter?

Apollo Endosurgery Inc (NASDAQ:APEN) released its quarterly earnings results on Thursday, March, 26th. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.38) by $0.04. Apollo Endosurgery had a negative net margin of 54.09% and a negative return on equity of 237.39%. View Apollo Endosurgery's earnings history.

What price target have analysts set for APEN?

1 brokers have issued twelve-month price objectives for Apollo Endosurgery's stock. Their forecasts range from $4.50 to $4.50. On average, they expect Apollo Endosurgery's share price to reach $4.50 in the next twelve months. This suggests a possible upside of 107.4% from the stock's current price. View analysts' price targets for Apollo Endosurgery.

Has Apollo Endosurgery been receiving favorable news coverage?

Headlines about APEN stock have been trending very negative on Friday, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Apollo Endosurgery earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutApollo Endosurgery.

Are investors shorting Apollo Endosurgery?

Apollo Endosurgery saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 181,900 shares, an increase of 31.7% from the February 13th total of 138,100 shares. Based on an average trading volume of 14,700 shares, the short-interest ratio is currently 12.4 days. Currently, 1.5% of the company's stock are short sold. View Apollo Endosurgery's Current Options Chain.

Who are some of Apollo Endosurgery's key competitors?

What other stocks do shareholders of Apollo Endosurgery own?

Who are Apollo Endosurgery's key executives?

Apollo Endosurgery's management team includes the following people:
  • Mr. Todd Newton, CEO & Director (Age 56)
  • Dr. Sergey Kantsevoy M.D., Co-Founder and Innovation Partner
  • Mr. Anthony Kalloo M.D., Co-Founder and Innovation Partner
  • Dr. Robert Hawes M.D., Co-Founder and Innovation Partner
  • Dr. Peter Benjamin Cotton M.D., Co-Founder and Innovation Partner

What is Apollo Endosurgery's stock symbol?

Apollo Endosurgery trades on the NASDAQ under the ticker symbol "APEN."

How do I buy shares of Apollo Endosurgery?

Shares of APEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apollo Endosurgery's stock price today?

One share of APEN stock can currently be purchased for approximately $2.17.

How big of a company is Apollo Endosurgery?

Apollo Endosurgery has a market capitalization of $45.44 million and generates $50.71 million in revenue each year. The biotechnology company earns $-27,430,000.00 in net income (profit) each year or ($1.53) on an earnings per share basis. Apollo Endosurgery employs 215 workers across the globe. View additional information about Apollo Endosurgery.

What is Apollo Endosurgery's official website?

The official website for Apollo Endosurgery is http://www.apolloendo.com/.

How can I contact Apollo Endosurgery?

Apollo Endosurgery's mailing address is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. The biotechnology company can be reached via phone at 512-279-5100 or via email at [email protected]

This page was last updated on 4/10/2020 by MarketBeat.com Staff

Featured Article: Candlestick

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel